Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases
Condition(s):Pancreatic Adenocarcinoma; Liver MetastasesLast Updated:January 8, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Pancreatic Adenocarcinoma; Liver MetastasesLast Updated:January 8, 2024Recruiting
Condition(s):Stage IV Fallopian Tube Cancer AJCC v6 and v7; Stage IV Ovarian Cancer AJCC v6 and v7; Stage IV Primary Peritoneal Cancer AJCC v7Last Updated:July 2, 2020Completed
Condition(s):Colon Cancer; Rectal CancerLast Updated:July 1, 2021Completed
Condition(s):Liver and Intrahepatic Bile Duct Carcinoma; Stage III Intrahepatic Cholangiocarcinoma AJCC v8; Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8; Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8; Stage IV Intrahepatic Cholangiocarcinoma AJCC v8; Unresectable Intrahepatic CholangiocarcinomaLast Updated:March 8, 2024Active, not recruiting
Condition(s):Colorectal Cancer; Metastatic CancerLast Updated:May 15, 2013Terminated
Condition(s):Gastric Cancer; Gastric Adenocarcinoma; Esophageal CancerLast Updated:January 8, 2018Terminated
Condition(s):Colorectal Cancer; Liver Metastases; Chemotherapy EffectLast Updated:August 31, 2023Recruiting
Condition(s):Hepatic CancerLast Updated:April 4, 2023Completed
Condition(s):Nasopharyngeal Carcinoma; Neoplasm Metastasis; LiverLast Updated:March 15, 2019Completed
Condition(s):Colorectal Cancer; Metastatic CancerLast Updated:July 6, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.